Showing results (21-30 of 117) with videos related to
Sort By:
Pageof 12
European Journal of Immunology|April 12, 2011
Modulation of human T-cell functions by reactive nitrogen speciesTihana Kasic, Piergiuseppe Colombo, Cristiana Soldani, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|May 26, 2007
Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies?Fabio Grizzi, Piergiuseppe Colombo, Gianluigi Taverna, et al.Chemotherapy|June 17, 2010
Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancerFrancesco Sclafani, Carlo Carnaghi, Piergiuseppe Colombo, et al.BJU International|July 16, 2011
Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy samplingGianluigi Taverna, Giovanni Morandi, Mauro Seveso, et al.Journal of Surgical Oncology|April 11, 2016
Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cavaFerdinando Carlo Maria Cananzi, Chiara Mussi, Maria Grazia Bordoni, et al.Frontiers in Immunology|October 22, 2025
Predicting immune checkpoint inhibitors response via fluorescence lifetime imaging microscopy: a systematic reviewCarlo Cossa, Giulio Frigato, Massimo Lupo, et al.Surgical Neurology|August 1, 2006
Spinal decompression and vertebroplasty in Paget's disease of the spineFlavio Tancioni, Antonio Di Ieva, Daniel Levi, et al.Endocrine-Related Cancer|January 7, 2016
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumoursEleonora Vitali, Valeria Cambiaghi, Alessandro Zerbi, et al.Pathology, Research and Practice|February 24, 2009
Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchymaGianluigi Taverna, Piergiuseppe Colombo, Fabio Grizzi, et al.Journal of Oncology|August 1, 2012
Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?Gianluigi Taverna, Luigi Benecchi, Fabio Grizzi, et al.Pageof 12